{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T01:32:57Z","timestamp":1789263177184,"version":"build-2803163510"},"reference-count":44,"publisher":"The Journal of Rheumatology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To evaluate the feasibility of studying creatine in juvenile dermatomyositis (JDM). Secondary objectives were to determine the effect of creatine on muscle function and metabolism, aerobic capacity, fatigue, physical activity, and quality of life (QOL), as well as its safety.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We conducted a 6-month, double-blind, randomized, multiple-baseline design; patients were assigned to creatine or placebo. Feasibility was assessed using attended study visits, completed study procedures, and adherence. Muscle function, aerobic capacity, and muscle strength were assessed with standardized exercise tests. Muscle metabolism was assessed using a 31-Phosphorus Magnetic Resonance Spectroscopy protocol. Fatigue, physical activity, and QOL were assessed by questionnaires. Statistical significance was estimated using a randomization (permutation) test. Changes in outcome measures taken at baseline and end-of-study were calculated using paired <jats:italic>t<\/jats:italic>-tests.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Median (range) adherence to the study drug was 88.5% (20.5\u201395.5%) and the proportion of subjects with 80% adherence or higher was 76.9%. There were no missed study visits. There were no statistically significant changes in muscle function, strength, aerobic capacity, disease activity, fatigue, physical activity, or QOL while subjects were receiving creatine compared to placebo. There were statistically significant adaptations in muscle metabolism (e.g., decrease in change in muscle pH following exercise, and decrease in phosphate\/phosphocreatine ratio) at the end-of-study compared to baseline. There were no significant adverse effects.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Creatine supplementation in children with JDM is feasible to study, and is safe and well-tolerated; it may lead to improvements in muscle metabolism.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.191375","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T16:15:13Z","timestamp":1596298513000},"page":"434-441","source":"Crossref","is-referenced-by-count":18,"title":["The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis: A Randomized, Double-blind, Placebo-controlled Feasibility Study"],"prefix":"10.3899","volume":"48","author":[{"given":"Saunya","family":"Dover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Schneiderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Pullenayegum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg D.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Anne","family":"Marcuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Tein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2020,8,1]]},"reference":[{"key":"2022070101451354000_48.3.434.1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0031-3955(16)40054-4","article-title":"Juvenile dermatomyositis. Pathophysiology and disease expression","volume":"42","author":"Pachman","year":"1995","journal-title":"Pediatr Clin North Am"},{"key":"2022070101451354000_48.3.434.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10237"},{"key":"2022070101451354000_48.3.434.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.21066"},{"key":"2022070101451354000_48.3.434.4","first-page":"1075","article-title":"Aerobic exercise capacity in patients with juvenile dermatomyositis","volume":"30","author":"Takken","year":"2003","journal-title":"J Rheumatol"},{"key":"2022070101451354000_48.3.434.5","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000240362.32089.4c"},{"key":"2022070101451354000_48.3.434.6","doi-asserted-by":"publisher","DOI":"10.1139\/h03-063"},{"key":"2022070101451354000_48.3.434.7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1573397052954235","article-title":"Pathophysiological factors which determine exercise intolerance in patients with juvenile dermatomyositis","volume":"1","author":"Takken","year":"2005","journal-title":"Curr Rheumatol Rev"},{"key":"2022070101451354000_48.3.434.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.22687"},{"key":"2022070101451354000_48.3.434.9","first-page":"CD004760","article-title":"Creatine for treating muscle disorders","volume":"2013","author":"Kley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2022070101451354000_48.3.434.10","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200010)43:10<2359::AID-ANR25>3.0.CO;2-D"},{"key":"2022070101451354000_48.3.434.11","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6486-9_16"},{"key":"2022070101451354000_48.3.434.12","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1152\/jappl.2001.91.3.1041","article-title":"Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis","volume":"91","author":"Parise","year":"2001","journal-title":"J Appl Physiol"},{"key":"2022070101451354000_48.3.434.13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C"},{"key":"2022070101451354000_48.3.434.14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/mus.24681","article-title":"Efficacy and safety of creatine supplementation in juvenile dermatomyositis: a randomized, double-blind, placebo-controlled crossover trial","volume":"53","author":"Solis","year":"2016","journal-title":"Muscle Nerve"},{"key":"2022070101451354000_48.3.434.15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00220970209599504","article-title":"Statistical power of randomization tests used with multiple-baseline designs","volume":"70","author":"Ferron","year":"2002","journal-title":"J Exp Educ"},{"key":"2022070101451354000_48.3.434.16","doi-asserted-by":"publisher","DOI":"10.1042\/cs0830367"},{"key":"2022070101451354000_48.3.434.17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1152\/jappl.1996.81.1.232","article-title":"Muscle creatine loading in men","volume":"81","author":"Hultman","year":"1996","journal-title":"J Appl Physiol"},{"key":"2022070101451354000_48.3.434.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-2863(97)00116-2"},{"key":"2022070101451354000_48.3.434.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197502132920706"},{"key":"2022070101451354000_48.3.434.20","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1212\/WNL.52.4.854","article-title":"Creatine monohydrate increases strength in patients with neuromuscular disease","volume":"52","author":"Tarnopolsky","year":"1999","journal-title":"Neurology"},{"key":"2022070101451354000_48.3.434.21","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000125178.18862.9D"},{"key":"2022070101451354000_48.3.434.22","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.8.734"},{"key":"2022070101451354000_48.3.434.23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/art.23250","article-title":"Responsiveness of exercise parameters in children with inflammatory myositis","volume":"59","author":"Takken","year":"2008","journal-title":"Arthritis Care Res"},{"key":"2022070101451354000_48.3.434.24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg210"},{"key":"2022070101451354000_48.3.434.25","first-page":"218","article-title":"Power output and fatigue of human muscle in maximal cycling exercise","volume":"55","author":"McCartney","year":"1983","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"2022070101451354000_48.3.434.26","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/art.23089","article-title":"Reliability of exercise testing and functional activity questionnaires in children with juvenile arthritis","volume":"57","author":"Stephens","year":"2007","journal-title":"Arthritis Care Res"},{"key":"2022070101451354000_48.3.434.27","doi-asserted-by":"publisher","DOI":"10.1249\/00005768-198606000-00002"},{"key":"2022070101451354000_48.3.434.28","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-198704060-00001"},{"key":"2022070101451354000_48.3.434.29","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00005768-199609000-00002","article-title":"Optimization of force in the Wingate Test for children with a neuromuscular disease","volume":"28","author":"Van Mil","year":"1996","journal-title":"Med Sci Sports Exerc"},{"key":"2022070101451354000_48.3.434.30","doi-asserted-by":"publisher","DOI":"10.1080\/02701367.2004.10609165"},{"key":"2022070101451354000_48.3.434.31","unstructured":"Canadian Society for Exercise Physiology . The Canadian physical activity, fitness and lifestyle approach: CSEP - health and fitness program\u2019s health-related appraisal and counselling strategy. Ottawa: Canadian Society for Exercise Physiology; 2003."},{"key":"2022070101451354000_48.3.434.32","unstructured":"Golding LA , Myers CR , Sinning WE. Y\u2019s way to physical fitness: the complete guide to fitness testing and instruction. YMCA of the USA; 1982."},{"key":"2022070101451354000_48.3.434.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.20349"},{"key":"2022070101451354000_48.3.434.34","unstructured":"Physiology CSfE . Canadian society for exercise physiology-physical activity training for health (CSEP-PATH). Canadian Society for Exercise Physiology; 2013."},{"key":"2022070101451354000_48.3.434.35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1139\/h00-028","article-title":"Canadian musculoskeletal fitness norms","volume":"25","author":"Payne","year":"2000","journal-title":"Can J Appl Physiol"},{"key":"2022070101451354000_48.3.434.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.558"},{"key":"2022070101451354000_48.3.434.37","first-page":"2494","article-title":"The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity","volume":"31","author":"Varni","year":"2004","journal-title":"J Rheumatol"},{"key":"2022070101451354000_48.3.434.38","first-page":"226","article-title":"Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care","volume":"27","author":"Feldman","year":"2000","journal-title":"J Rheumatol"},{"key":"2022070101451354000_48.3.434.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2005.00066.x"},{"key":"2022070101451354000_48.3.434.40","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-2-12"},{"key":"2022070101451354000_48.3.434.41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1123\/pes.15.3.257","article-title":"Validation of a 3-day physical activity recall instrument in female youth","volume":"15","author":"Pate","year":"2003","journal-title":"Pediatr Exerc Sci"},{"key":"2022070101451354000_48.3.434.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7130.549"},{"key":"2022070101451354000_48.3.434.43","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20532"},{"key":"2022070101451354000_48.3.434.44","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000258615.42478.55"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.191375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T08:47:11Z","timestamp":1656665231000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.191375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,1]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.3899\/jrheum.191375"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.191375","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}